Baylor University, NexTel Medical Corp., and LMMY are finalizing the Manufacturing Transfer Agreement (MTA) for clinical testing of Maxasome Plus, achieving a 75% equity stake.
4 reports, 1 independent
Updated Aug 6
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Baylor University, NexTel Medical Corp., and LMMY are finalizing the Manufacturing Transfer Agreement (MTA) for clinical testing of Maxasome Plus, achieving a 75% equity stake.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Baylor University
private Baptist university in Waco, Texas, United States